Mural Oncology (MURA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mural Oncology

    NASDAQ: MURA · Real-Time Price · USD
    2.08
    0.00 (0.00%)
    At close: Oct 06, 2025, 10:12 AM

    Mural Oncology Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -128.51M -207.45M -189.81M -175.43M
    Depreciation & Amortization
    		 3.51M 2.57M 1.54M 1.47M
    Stock-Based Compensation
    		 5.08M 24.11M 11.93M 11.5M
    Other Working Capital
    		 -11.54M -13.48M 7.75M 5.79M
    Other Non-Cash Items
    		 -2.58M n/a 15.01M 14.45M
    Deferred Income Tax
    		 n/a n/a -15.01M -14.45M
    Change in Working Capital
    		 -6.05M -13.48M 7.75M 5.79M
    Operating Cash Flow
    		 -128.54M -194.25M -168.59M -156.67M
    Capital Expenditures
    		 -92K -3.45M -5.51M -4.38M
    Cash Acquisitions
    		 67K n/a n/a n/a
    Purchase of Investments
    		 -167.31M n/a n/a n/a
    Sales Maturities Of Investments
    		 142M n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -25.33M -3.45M -5.51M -4.38M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 468.81M 174.1M 161.05M
    Financial Cash Flow
    		 196K 468.81M 174.1M 161.05M
    Net Cash Flow
    		 -153.68M 271.11M n/a n/a
    Free Cash Flow
    		 -128.64M -197.7M -174.1M -161.05M

    Add to Watchlist